Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies av Mushtaq Y, Mushtaq MM, Gatzioufas Z, Ripa M, Motta L, Panos GD

Hämta fulltext

Faricimab: Transforming the Future of Macular Diseases Treatment - A Comprehensive Review of Clinical Studies av Panos GD, Lakshmanan A, Dadoukis P, Ripa M, Motta L, Amoaku WM

Hämta fulltext

"BASUCO" Resumen del Foro sobre "Basuco" organizado por la Asociación Colombiana de Toxicología y Farmacodependencia av Jairo Arévalo, Jesús Idrobo, Evaristo Arévalo, Camilo Uribe, Germán Motta L., Luis Enciso

Hämta fulltext

Defining the role of AP1 in molecular adaptation to hypoxia in colorectal cancer av Vancauwenberghe, E, Bolland, H, Carroll, C, Da Motta, L, Grabowska, A, Buffa, F, Harris, A, McIntyre, A

SAÚDE MENTAL X VULNERABILIDADE SOCIAL: UMA INTERVENÇÃO COM MORADORES DA TAMARINDO av SANTOS, J.C.R.F, ANDRADE, E.R, ALMEIDA, L.P, BRITO, H.P.P, CARVALHO, G.R., MOTTA, L.T.S

Hämta fulltext

Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysis av Fiscone, C, Sighinolfi, G, Manners, DN, Motta, L, Venturi, G, Panzera, I, Zaccagna, F, Rundo, L, Lugaresi, A, Lodi, R, Tonon, C, Castelli, M

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC) av Harris, A, da Motta, L, Ledaki, I, Purshouse, K, Haider, S, De Bastiani, M, Babin, D, Morotti, M, Steers, G, Wigfield, S, Bridges, E, Knapp, S, Ebner, D, Klimt, F, McIntyre, A

Bioarchaeology aids the cultural understanding of six characters in search of their agency (Tarquinia, ninth–seventh century BC, central Italy) av Bagnasco, G, Marzullo, M, Cattaneo, C, Biehler-Gomez, L, Mazzarelli, D, Ricciardi, V, Müller, W, Coppa, A, McLaughlin, R, Motta, L, Prato, O, Schmidt, F, Gaveriaux, F, Marras, GB, Millet, MA, Madgwick, R, Ballantyne, R, Makarewicz, C, Trentacoste, A, Reimer, P, Mattiangeli, V, Bradley, DG, Malone, C, Esposito, C

Integrating metabolomics, genomics and disease pathways in age-related macular degeneration: The EYE-RISK Consortium av Acar, IE, Lores-Motta, L, Colijn, JM, Meester-Smoor, MA, Verzijden, T, Cougnard-Gregoire, A, Ajana, S, Merle, BMJ, de Breuk, A, Heesterbeek, TJ, van den Akker, E, Daha, MR, Claes, B, Pauleikhoff, D, Hense, H-W, van Duijn, CM, Fauser, S, Hoyng, CB, Delcourt, C, Klaver, CCW, Galesloot, TE, den Hollander, AI, EYE-RISK Consortium